Surrozen, Inc.
SRZNNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $631.42M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $11.39$37.83
- Volume (live)
- -
- Avg. volume (3M)
- 923.73K
Surrozen (SRZN) Stock Price & Financial Analysis
Surrozen Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $24.97 - $27.75 |
|---|---|
| 52-Week High | $37.83 |
| 52-Week Low | $11.39 |
| Open | $25.23 |
| Volume (last close) | 511.21K |
| Average Volume (3M) | 923.73K |
| Revenue (TTM) | 11.51M |
|---|---|
| Net Income (TTM) | -332.13M |
| Free Cash Flow (TTM) | -34.98M |
| EPS (TTM) | −$25.66 |
| Profit Margin | -2885.33% |
| Operating Margin | -385.28% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 631.42M |
|---|---|
| Shares Outstanding | 23.15M |
| Price to Sales (P/S) | 54.85 |
| Price to Book (P/B) | -2.89 |
| EV/EBITDA | -3.10 |
| 50-Day MA | $23.71 |
|---|---|
| 200-Day MA | $24.76 |
| 1-Year Change | +87.89% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Surrozen at a Glance
As of the Oct 26, 2026 close, Surrozen (SRZN) has a market capitalization of $631.42M. The stock trades at 54.9× sales. Over the trailing twelve months it lost $332.13M on revenue of $11.51M and burned $34.98M of free cash flow. Revenue grew 251.4% year over year.
As of its latest reported balance sheet, it holds $102.04M in cash and securities against $6.32M of debt, a net cash position of $95.72M.
Surrozen does not currently pay a dividend.
The share price is up 87.9% over the past year. At $27.28 (the Oct 26, 2026 close) it sits within its 52-week range of $11.39 to $37.83, above its 200-day moving average of $24.76.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $47.50, 74.1% above the Oct 26, 2026 close.
Frequently Asked Questions About Surrozen
What is the current stock price for SRZN?
As of the Oct 26, 2026 close, SRZN stock trades at $27.28. The 52-week range is $11.39–$37.83, with a day range of $24.97–$27.75.
What is the P/E ratio for SRZN?
The P/E ratio (Price-to-Earnings) for SRZN is shown in the Key Statistics section. This valuation metric helps compare Surrozen, Inc. to industry peers.
Does SRZN pay dividends?
Surrozen does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SRZN?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for SRZN is Buy. The average 12-month price target is $47.50, a 74.1% upside from the Oct 26, 2026 close of $27.28.
What is the market cap of SRZN?
As of the Oct 26, 2026 close, Surrozen's market capitalization is $631.4M, classifying it as a small-cap company. Surrozen operates in the Healthcare sector within the Biotechnology industry.